31
Ben Yedidia Tamar, Singer Yossi: Multimeric multiepitope influenza vaccines. Biondvax Pharmaceuticals, Ben Yedidia Tamar, Singer Yossi, WEBB PO Box 2189 76121 Rehovot, February 5, 2009: WO/2009/016639 (7 worldwide citation)

The present invention relates to multimeric multi-epitope peptide-based vaccines. In particular, the present invention relates to the use of multimeric multi-epitope peptide-based vaccines eliciting protective immunity to influenza.


32
D Aoust Marc Andre, Couture Manon, Ors Frédéric, Trepanier Sonia, Lavoie Pierre Olivier, Dargis Michèle, Vezina Louis Philippe, Landry Nathalie: Influenza virus-like particles (vlps) comprising hemagglutinin. Medicago, D Aoust Marc Andre, Couture Manon, Ors Frédéric, Trepanier Sonia, Lavoie Pierre Olivier, Dargis Michèle, Vezina Louis Philippe, Landry Nathalie, Sechley Konrad A, January 14, 2010: WO/2010/003225 (7 worldwide citation)

A method for synthesizing influenza virus-like particles (VLPs) within a plant or a portion of a plant is provided. The method involves expression of influenza HA of type A/California/04/09 in plants and the purification by size exclusion chromatography. The invention is also directed towards a VLP ...


33
COUTURE MANON: Chimeric influenza virus-like particles comprising hemagglutinin. MEDICAGO, Sechley Konrad A, December 29, 2010: WO/2010/148511 (7 worldwide citation)

A method for synthesizing chimeric influenza virus-like particles (VLPs) within a plant or a portion of a plant is provided. The method involves expression of chimeric influenza HA in a plant or a portion of a plant. The invention is also directed towards a VLP comprising chimeric influenza HA prote ...


34
De, Wit Emmie, Spronken Monique Ij, Fouchier Ron Am, Osterhaus Albert Dme: Rescue of influenza virus. Solvay Pharmaceuticals, Erasmus University Medical Center Rotterdam, de, Wit Emmie, Spronken Monique Ij, Fouchier Ron Am, Osterhaus Albert Dme, AERTS Robert J, June 29, 2006: WO/2006/067211 (6 worldwide citation)

The invention relates to the field of influenza vaccine production. Influenza vaccines have been produced in embryonated hens'eggs for over 50 years, but recently there have been considerable efforts to develop cell culture systems for vaccine production. The invention provides a nucleic acid compri ...


35
Gregersen Jens Peter: Decreasing potential iatrogenic risks associated with influenza vaccines. Novartis Vaccines And Diagnostics & Co Kg, Gregersen Jens Peter, MARSHALL Cameron John, March 16, 2006: WO/2006/027698 (6 worldwide citation)

Influenza viruses for use in preparing human vaccines have traditionally been grown on embryonated hen eggs, although more modern techniques grow the virus in mammalian cell culture e.g. on Vero, MDCK or PER.C6 cell lines. The inventor has realised that the conditions used for influenza virus 5 cult ...


36
YUSIBOV VIDADI: Influenza vaccines, antigens, compositions, and methods. FRAUNHOFER USA, Phillips Eifion, April 1, 2010: WO/2010/036970 (6 worldwide citation)

The present invention relates to the intersection of the fields of immunology and protein engineering, and particularly to antigens and compositions useful in inducing or enhancing an immune response agains influenza antigens. Provided are recombinant protein antigens, compositions, and methods for ...


37
Tsai Theodore F, Trusheim Heidi: Making influenza virus vaccines without using eggs. Novartis, Tsai Theodore F, Trusheim Heidi, MARSHALL Cameron John, March 20, 2008: WO/2008/032219 (6 worldwide citation)

Currently, the steps performed prior to release of influenza strains to vaccine manufacturers involve passaging influenza virus through eggs. The invention aims to provide procedures useful in manufacturing influenza vaccines, in which the use of eggs is reduced, and preferably is avoided altogether ...


38
Uytdehaag Alphonsus Gerardus Cornelis Maria, Pau Maria Grazia, Schouten Govert: Production influenza virus vaccines. Crucell Holland, Uytdehaag Alphonsus Gerardus Cornelis Maria, Pau Maria Grazia, Schouten Govert, HATEBOER Guus, April 26, 2007: WO/2007/045674 (6 worldwide citation)

Means and methods for producing mammalian viruses, the method comprising infecting a culture of immortalized human cells with a virus, incubating the culture infected with virus to propagate the virus under conditions that permit growth of t he virus, and to form a virus-containing medium, and remov ...


39
Banzhoff Angelika, Clemens Ralf: Combined influenza vaccines for seasonal and pandemic protection. Novartis, Banzhoff Angelika, Clemens Ralf, Marshall Cameron John, December 17, 2009: WO/2009/150532 (6 worldwide citation)

Current approaches to influenza vaccination focus either on seasonal strains or pandemic strains. Current seasonal vaccines typically include antigens from two influenza A strains (H1N1 and H3N2) and one influenza B strain. Current pandemic vaccines focus on H5N1 influenza A virus strains. It is an ...


40
George Kemble, Gregory Duke: Multi plasmid system for the production of influenza virus. Medimmune, Grant Anderson, January 10, 2012: US08093033 (5 worldwide citation)

Vectors and methods for the production of influenza viruses suitable as recombinant influenza vaccines in cell culture are provided. Bi-directional expression vectors for use in a multi-plasmid influenza virus expression system are provided. Additionally, the invention provides methods of producing ...



Click the thumbnails below to visualize the patent trend.